'Drugmaker Biocon in talks with Mylan to merge biosimilar businesses'
Indian drugmaker Biocon Ltd is in talks with generic drugmaker Mylan for a merger of their biosimilar businesses, a financial news website reported on Thursday, citing sources with direct knowledge of the matter.
Biocon will seek to hold a controlling majority stake in the merged entity. Pic: https://twitter.com/Bioconlimited and https://www.mylan.in/